Faculty of Sport Sciences, University of Birjand
Birjand, South Khorasan Province, 9717434765, Iran
NCT Number: NCT07830459
This study compares the effects of acute (single-session) and short-term (7-day) consumption of different doses of caffeine (3 and 6 mg/kg) on maximal strength, strength endurance, vertical jump, and medicine ball throw performance in habitual caffeine-consuming women (daily intake of 5 mg/kg). Thirty-six resistance-trained women were randomly assigned to three groups: 3 mg/kg caffeine, 6 mg/kg caffeine, or placebo in a double-blind crossover design. Participants completed both acute (60 min pre-exercise) and short-term (7 consecutive days) protocols. The main findings showed that acute ingestion of 6 mg/kg caffeine impaired peak power in the maximal strength test, while short-term consumption of the same dose improved peak power in the strength-endurance test. The 3 mg/kg dose was ineffective in all conditions. Caffeine did not affect jump or throw performance. The study highlights the need for individualized caffeine guidelines based on timing, dosage, and habituation status.
Looking for future studies?
Notify Me20 year–30 year
Female
Interventional
Not applicable
Birjand, South Khorasan Province, 9717434765, Iran
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Absence of neuromuscular and musculoskeletal disorders
At least 2 years of regular resistance training experience (minimum 3 sessions per week)
At least 6 months of resistance training prior to enrollment
Absence of renal and hepatic disorders
Daily caffeine consumption of 5 mg/kg body weight (based on questionnaire)
No use of specific medications or supplements that could affect study outcomes (e.g., beta-alanine, creatine, pre-workout supplements) -
Exclusion criteria
Occurrence of any injury during the study
Failure to adhere to the supplement consumption protocol
Withdrawal from the study-
Caffeine powder (99% purity) encapsulated in gelatin capsules at a dose of 3 mg per kilogram of body weight. The capsules are identical in appearance, odor, and taste to the placebo. Participants consume the capsules daily for 7 consecutive days. On the testing day, the capsules are ingested 60 minutes prior to the exercise tests.
Caffeine powder (99% purity) encapsulated in gelatin capsules at a dose of 6 mg per kilogram of body weight. The capsules are identical in appearance, odor, and taste to the placebo. Participants consume the capsules daily for 7 consecutive days. On the testing day, the capsules are ingested 60 minutes prior to the exercise tests.
Placebo capsules containing inert flour (or microcrystalline cellulose), identical in appearance, odor, and taste to the caffeine capsules. Participants consume the capsules daily for 7 consecutive days. On the testing day, the capsules are ingested 60 minutes prior to the exercise tests.
Time frame: Baseline, 60 minutes post-ingestion (acute), and after 7 days of supplementation (short-term)
Peak concentric power (Watts) during 1-RM bench press test, measured using a validated Kinect camera
Time frame: Baseline, 60 minutes post-ingestion (acute), and after 7 days of supplementation (short-term)
eak concentric power (Watts) during bench press at 50% of 1-RM to failure, measured using Kinect camera
Time frame: Baseline, 60 minutes post-ingestion (acute), and after 7 days of supplementation (short-term)
Distance (cm) of 3-kg medicine ball throw from chest position
Time frame: Baseline, 60 minutes post-ingestion (acute), and after 7 days of supplementation (short-term)
Countermovement jump height (cm) measured using Kinect camera
Time frame: Baseline, 60 minutes post-ingestion (acute), and after 7 days of supplementation (short-term)
Number of repetitions performed at 50% of 1-RM until failure
Birjand University of Medical Sciences
Other
Comparison Effects of Acute and Short-Term Consumption of Different Doses of Caffeine on Strength and Power Indices in Habitual Caffeine-Consuming Women
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05170139
Athletic Performance, Caffeine
Zaragoza, Spain
View Trial DetailsNCT07771556
Behavior, Caffeine
Birjand, South Khorasan Province, Iran
View Trial DetailsNCT07404254
Beverage Intake, Caffeine
San Francisco, California, United States
View Trial DetailsNCT07357818
Beverage Intake, Caffeine
San Francisco, California, United States
View Trial Details